Valuation dashboard for Lifeward Ltd. (LFWD) with P/E N/A, P/B 1.58, EV/EBITDA -4.27 and dividend yield 0.00%. DCF, Graham Number and Earnings Power Value models plus sector comparison against other Healthcare companies.
Lifeward Ltd. is a healthcare technology company specializing in the creation, development, and commercialization of wearable robotic exoskeletons. These sophisticated devices are engineered to restore lower limb mobility for individuals living with spinal cord injuries (SCI), granting them the ability to stand, walk, pivot, and navigate staircases by providing assistive hip and knee motion.
Analysis Summary
Lifeward Ltd. reported revenue of $22.0M in the most recent fiscal year, growing at a 5-year CAGR of 38.1%.
Trailing-twelve-month margins: gross margin 36.0%, operating margin -104.2%, net margin -141.3%.
At the current price of $6.91, LFWD has negative trailing earnings (P/E not meaningful) and an ROE of -236.85%. Market capitalisation stands at $11M.
Balance sheet quality for LFWD: current ratio of 1.3. A debt-to-equity below 1.0 typically signals conservative capital structure, while a current ratio above 1.5 indicates comfortable short-term liquidity.
Valuation Ratios
| Price / Book | 1.58 |
| EV / EBITDA | -4.27 |
| Dividend Yield | 0.00% |
Valuation Models
| DCF Fair Value | $-188.47 |
| vs Current Price | -2827.5% |
Peer Comparison
| Symbol | Company | Market Cap | P/E | P/B | ROE |
|---|---|---|---|---|---|
| LFWD | Lifeward Ltd. | $11M | 1.58 | -236.8% | |
| ABT | Abbott Laboratories | $177.1B | 32.49 | 3.45 | 10.5% |
| 0Y6X.L | Medtronic Plc | $125.7B | |||
| MDT | Medtronic plc | $118.5B | 22.97 | 2.39 | 10.6% |
| SYK | Stryker Corporation | $109.2B | 29.95 | 4.66 | 16.4% |
| 0R2S.L | Stryker Corporation | $107.9B | 29.27 | 4.55 | 16.4% |
| 0HOY.L | Boston Scientific Corporation | $66.5B | 48.91 | 5.86 | 11.9% |
| BSX | Boston Scientific Corporation | $65.3B | 17.73 | 2.61 | 14.9% |
Price
| Price | $6.91 |
| Market Cap | $11M |
| Exchange | NASDAQ |
| Country | IL |
Profitability
| Return on Equity | -236.85% |
| Return on Invested Capital | -119.56% |
| Return on Assets | -86.96% |
| Gross Margin | 35.95% |
| Operating Margin | -104.25% |
| Net Margin | -141.28% |
Related companies: DHAI · IINN · INAB · LYRA · PTHL · RNAZ · SBFM
Explore sector: Healthcare · Medical - Devices
More sections of LFWD: Overview · Financials · Statistics · Estimates · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks